Skip to content

Cipla recalls six batches of bronchospasm treatment inhalation aerosol in US

The company#39;s wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing.

Read More

​ The company#39;s wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing. The company#39;s wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish